1. Home
  2. TTRX vs GECC Comparison

TTRX vs GECC Comparison

Compare TTRX & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.42

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

GECC

Great Elm Capital Corp.

HOLD

Current Price

$5.75

Market Cap

101.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
GECC
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
101.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TTRX
GECC
Price
$3.42
$5.75
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$8.00
$10.75
AVG Volume (30 Days)
17.3K
75.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
25.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$32.31
Revenue Next Year
N/A
$1.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$5.64
52 Week High
$5.98
$11.45

Technical Indicators

Market Signals
Indicator
TTRX
GECC
Relative Strength Index (RSI) 42.29 26.47
Support Level $2.64 N/A
Resistance Level $5.12 $7.16
Average True Range (ATR) 0.23 0.28
MACD 0.02 -0.06
Stochastic Oscillator 29.58 7.46

Price Performance

Historical Comparison
TTRX
GECC

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.

Share on Social Networks: